Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients
暂无分享,去创建一个
I. Ellis | A. Green | E. Rakha | V. Band | H. Band | Xiangshan Zhao | S. Mirza | S. Lele | A. Alshareeda | Ying Zhang | Shakur Mohibi | J. H. Kim | C. Gurumurthy | Aditya Bele | Fang Qiu | Monica Goswami | William West
[1] A. Jemal,et al. Global Cancer Statistics , 2011 .
[2] V. Band,et al. Biochemical characterization of human Ecdysoneless reveals a role in transcriptional regulation , 2010, Biological chemistry.
[3] V. Band,et al. Role of Mammalian Ecdysoneless in Cell Cycle Regulation* , 2009, The Journal of Biological Chemistry.
[4] Debra L Winkeljohn. Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.
[5] L. Carey,et al. What is triple-negative breast cancer? , 2008, European journal of cancer.
[6] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[7] D. Spandidos,et al. Human Papilloma Virus (HPV) and Host Cellular Interactions , 2008, Pathology & Oncology Research.
[8] A. Giordano,et al. From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathway , 2007, Journal of cellular biochemistry.
[9] Ian O Ellis,et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Warner,et al. Screening for hereditary breast cancer. , 2007, Seminars in oncology.
[11] W. Du,et al. Retinoblastoma family genes , 2006, Oncogene.
[12] Sam W. Lee,et al. The human orthologue of Drosophila ecdysoneless protein interacts with p53 and regulates its function. , 2006, Cancer research.
[13] J. Robertson,et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation , 2006, The Journal of pathology.
[14] M. Barbacid,et al. Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.
[15] G. Ball,et al. High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.
[16] Brian David Dynlacht,et al. New insights into cyclins, CDKs, and cell cycle control. , 2005, Seminars in cell & developmental biology.
[17] B. Clurman,et al. Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.
[18] P. Hinds,et al. Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.
[19] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[20] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[21] D. Rimm,et al. X-Tile , 2004, Clinical Cancer Research.
[22] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[23] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[24] V. Band. The role of retinoblastoma and p53 tumor suppressor pathways in human mammary epithelial cell immortalization. , 1998, International journal of oncology.
[25] C. Sherr. Cancer Cell Cycles , 1996, Science.
[26] L. Hengst,et al. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1 , 1995, Molecular and cellular biology.
[27] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[28] R. Weinberg,et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.
[29] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[30] E B Cox,et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.